Protagonist Therapeutics ... (PTGX)
48.88
-0.56 (-1.13%)
At close: Mar 28, 2025, 3:59 PM
48.88
0.00%
After-hours: Mar 28, 2025, 04:34 PM EDT
Protagonist Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Revenue | 434.43M | 60M | 26.58M | 27.36M | 28.63M | 231K | 30.93M | 20.06M | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | 1.03M | 2.77M | n/a | n/a | n/a | n/a | 317K | 247K | n/a |
| Gross Profit | 434.43M | 60M | 25.55M | 24.58M | 28.63M | 231K | 30.93M | 20.06M | -317K | -247K | n/a |
| Operating Income | 252.84M | -93.65M | -131.37M | -125.84M | -64.52M | -80.52M | -42.27M | -37.9M | -32.67M | -14.79M | -9.32M |
| Interest Income | 26.32M | 14.9M | 4.06M | 443K | 900K | 2.81M | 2.57M | 948K | 242K | 19K | 16K |
| Pretax Income | 279.41M | -78.95M | -127.39M | -125.55M | -64.84M | -77.88M | -39.72M | -36.96M | -37.18M | -14.86M | -11.07M |
| Net Income | 275.19M | -78.95M | -123.41M | -122.63M | -66.15M | -77.19M | -38.92M | -36.96M | -37.18M | -14.86M | -11.07M |
| Selling & General & Admin | 43.46M | 33.49M | 31.74M | 27.2M | 18.64M | 15.75M | 13.7M | 11.78M | 6.96M | 2.96M | 1.86M |
| Research & Development | 138.13M | 120.16M | 126.22M | 126.01M | 74.51M | 65M | 59.5M | 46.18M | 25.7M | 11.83M | 7.46M |
| Other Expenses | n/a | n/a | -80K | -149K | -46K | -1K | n/a | n/a | -34K | n/a | n/a |
| Operating Expenses | 181.59M | 153.65M | 157.95M | 153.2M | 93.14M | 80.75M | 73.19M | 57.96M | 32.67M | 14.79M | 9.32M |
| Interest Expense | n/a | n/a | n/a | n/a | 598K | 169K | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 181.59M | 153.65M | 157.95M | 153.2M | 93.14M | 80.75M | 73.19M | 57.96M | 32.67M | 14.79M | 9.32M |
| Income Tax | 4.22M | n/a | -3.98M | -2.92M | 1.3M | -691K | -799K | -406K | 4.16M | 64K | 1.75M |
| Shares Outstanding (Basic) | 61.57M | 56.76M | 49.04M | 46.32M | 34.4M | 25.89M | 22.36M | 17.69M | 6.5M | 5.88M | 5.88M |
| Shares Outstanding (Diluted) | 65.08M | 56.76M | 49.04M | 46.32M | 34.4M | 25.89M | 22.36M | 17.69M | 6.5M | 5.88M | 5.88M |
| EPS (Basic) | 4.47 | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
| EPS (Diluted) | 4.23 | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
| EBITDA | 252.84M | -90.34M | -131.37M | -123.07M | -63.66M | -78.31M | -39.2M | -36.55M | -32.35M | -14.55M | -9.06M |
| Depreciation & Amortization | n/a | 3.31M | 1.03M | 2.77M | 789K | 703K | 527K | 406K | 317K | 247K | 258K |